A Personalized Health & Longevity Blueprint
Prepared for: Jane Doe (Sample)
Date of Report: June 27, 2025
Overall, your metabolic health markers are strong, and cardiovascular indicators are within optimal ranges. The primary opportunities for optimization lie in reducing systemic inflammation (hs-CRP) and supporting your body's methylation cycle (Homocysteine). This report outlines specific, evidence-based strategies focusing on targeted supplementation and minor dietary adjustments to address these areas for enhanced long-term health.
Your Result
68 mg/dL
Optimal Range
< 80 mg/dL
Standard Range
< 130 mg/dL
ApoB is the most accurate measure of atherosclerotic cardiovascular disease risk. Your result is **excellent** and falls well within the optimal range for longevity, indicating a very low burden of atherogenic particles.
Maintain your current diet and exercise regimen, as it is clearly effective at managing lipoprotein levels.
Your Result
1.8 mg/L
Optimal Range
< 1.0 mg/L
Standard Range
< 3.0 mg/L
hs-CRP measures chronic, low-grade inflammation. Your result is in the 'average risk' category but is above the optimal range for longevity. This indicates a potential for low-level systemic inflammation that could be addressed.
Your Result
11.2 µmol/L
Optimal Range
< 9 µmol/L
Standard Range
< 15 µmol/L
Homocysteine is a marker for your body's methylation process, crucial for DNA repair and more. While technically "normal," your level is above the optimal range, suggesting an opportunity to improve this key pathway.
Based on your results, here are the highest-priority actions for the next 90 days to move your key markers toward optimal:
Introduce a daily Omega-3 supplement (2g EPA/DHA) and prioritize 7-8 hours of quality sleep to lower your hs-CRP.
Begin taking a daily B-Complex vitamin that includes methylfolate (B9) and methylcobalamin (B12) to help lower Homocysteine levels.
Continue your current positive lifestyle habits. Plan to re-test hs-CRP and Homocysteine in 3-4 months to confirm these interventions are effective.